A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Clinical trial NCT06773208 · RECRUITING
Trial details
- NCT number
- NCT06773208
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-07
- Primary completion
- 2027-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.